Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06407050 · ClinicalTrials.gov registry record · NA

Duration of Physical Inactivity and Postprandial Lipid Metabolism

A NA study of Metabolism, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06407050: Completed NA study of Metabolism, sponsored by University of Texas at Austin.

NCT06407050 is a NA study of Metabolism that has completed, run by University of Texas at Austin. The registered enrollment target is 8 participants, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06407050, a NA study of Metabolism, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate the effect of different periods of physical inactivity on postprandial lipid metabolism in the morning after exercise by measuring plasma triglyceride levels and fat oxidation (burning). The study is a crossover intervention with all healthy participants performing three trials varying in length of physical inactive (4 hours, 8 hours, and 12 hours). All trials include a physical activity control phase (\>8,500 steps/24hr), a physical inactive phase, a moderate intensity cycling session, and a high-fat tolerance test.

Primary Outcome

Exhaled gas will be collected during the high fat tolerance test. Fat oxidation will be calculated based on the gas volume and CO2 and O2 proportion.

Conditions Studied

Metabolism

Interventions

  • BEHAVIORAL 4 hours of physical inactivity
  • BEHAVIORAL 8 hours of physical inactivity
  • BEHAVIORAL 12 hours of physical inactivity

Study Locations (1)

Texas

  • The University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2024-04-01
Est. Completion 2024-11-01
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT06407050 record still lists

NCT06407050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Metabolism appearing as the primary indexed condition, and to 3 interventions - of which 4 hours of physical inactivity is the first listed.

NCT06407050 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06407050 about?

NCT06407050 is a clinical study titled "Duration of Physical Inactivity and Postprandial Lipid Metabolism". The purpose of the study is to investigate the effect of different periods of physical inactivity on postprandial lipid metabolism in the morning after exercise by measuring plasma triglyceride levels and fat oxidation (burning). The study is a crossover intervention with all healthy participants pe...

What is the current status of trial NCT06407050?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-04-01. Estimated completion is 2024-11-01.

What conditions does trial NCT06407050 study?

This clinical trial studies the following conditions: Metabolism.

What interventions are being tested in trial NCT06407050?

The interventions under investigation include: 4 hours of physical inactivity (BEHAVIORAL), 8 hours of physical inactivity (BEHAVIORAL), 12 hours of physical inactivity (BEHAVIORAL).

Who is sponsoring clinical trial NCT06407050?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06407050 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metabolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06407050's enrollment target sits among peer trials

8 17th of 19 higher than 2 of 19 other Metabolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metabolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06407050, the US trial registry maintained by the National Library of Medicine. NCT06407050 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.